Prostatic-specific Antigen Velocity After Holmium Laser Enucleation of the Prostate: Possible Predictor for the Assessment of Treatment Effect Durability for Benign Prostatic Hyperplasia and Detection of Malignancy

Elzayat, 2009, Holmium laser enucleation of the prostate in patients with prostate size <60 cm3, Urology, 73, 95, 10.1016/j.urology.2008.06.049 Kuntz, 2008, Holmium laser enucleation of the prostate versus open prostatectomy for prostate greater than 100 grams: 5 year follow up results of a randomized clinical trial, Eur Urol, 53, 160, 10.1016/j.eururo.2007.08.036 Peterson, 2005, Holmium laser enucleation of the prostate for men with urinary retention, J Urol, 174, 998, 10.1097/01.ju.0000170230.26743.e4 Elzayat, 2007, Holmium laser enucleation of the prostate (HoLEP): long-term results, reoperation rate and possible impact of the learning curve, Eur Urol, 52, 1465, 10.1016/j.eururo.2007.04.074 Tinmouth, 2005, Change in serum prostate specific antigen concentration after holmium laser enucleation of the prostate: a marker for completeness of adenoma resection?, J Endourol, 19, 550, 10.1089/end.2005.19.550 Shingleton, 2000, Prostate specific antigen measurements after minimally invasive surgery of the prostate in men with benign prostatic hypertrophy, Prostate Cancer Prostatic Dis, 3, 200, 10.1038/sj.pcan.4500476 Carter, 1992, Longitudinal evaluation of prostate–specific antigen levels in men with and without prostate disease, J Am Med Assoc, 267, 2215, 10.1001/jama.267.16.2215 Fang, 2002, PSA velocity for assessing prostate cancer risk in men with PSA levels between 2.0 and 4.0 ng/ml, Urology, 59, 889, 10.1016/S0090-4295(02)01646-1 Loeb, 2007, PSA velocity threshold for predicting prostate cancer in young men, J Urol, 177, 899, 10.1016/j.juro.2006.10.028 Raaijmakers, 2004, Prostate-specific antigen change in the European randomized study of screening for prostate cancer, section Rotterdam, Urology, 63, 316, 10.1016/j.urology.2003.09.028 Roobol, 2004, Prostate-specific antigen velocity at low prostate –specific levels as screening tool for prostate cancer: result of second screening round of ERSPC (Rotterdam), Urology, 63, 309, 10.1016/j.urology.2003.09.083 Schroder, 2006, Does PSA velocity predict prostate cancer in pre-screened population?, Eur Urol, 49, 460, 10.1016/j.eururo.2005.12.026 Smith, 1994, Rate of changes in serum prostate specific antigen levels as a method for prostate cancer detection, J Urol, 152, 1163, 10.1016/S0022-5347(17)32528-4 Berger, 2005, Longitudinal PSA changes in men with and without prostate cancer: assessment of prostate cancer risk, Prostate, 64, 240, 10.1002/pros.20210 Connolly, 2006, Methods of calculating prostate–specific antigen velocity, Eur Urol, 52, 1044, 10.1016/j.eururo.2006.12.017 Yu, 2006, Comparison of methods for calculating prostate specific antigen velocity, Oncology, 176, 2427 Fong, 2002, Video article, BJU Int, 90, 870, 10.1046/j.1464-410X.2002.03088.x El-Hakim, 2002, Holmium laser enucleation of the prostate can be taught: the first learning experience, BJU Int, 90, 863, 10.1046/j.1464-410X.2002.03071.x Stamey, 1987, Prostatic serum antigen as a serum marker for adenocarcinoma of the prostate, N Engl J Med, 317, 909, 10.1056/NEJM198710083171501 Aus, 1996, Reference range of prostatic specific antigen after transurethral resection of the prostate, Urology, 47, 529, 10.1016/S0090-4295(99)80489-0 Hai, 2003, Photoselective vaporization of the prostate: initial experience of a new 80 W KTP laser for the treatment of benign prostatic hyperplasia, J Endourol, 17, 93, 10.1089/08927790360587414 Te, 2006, Impact of prostate–specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicenter study at 3 years, BJU Int, 97, 1229, 10.1111/j.1464-410X.2006.06197.x Zlotta, 2003, Long term evaluation of transurethral needle ablation of the prostate(TUNA) for treatment of symptomatic benign prostatic hyperplasia: clinical outcome up to five years from three centers, Eur Urol, 44, 89, 10.1016/S0302-2838(03)00218-5 Marks, 1996, Serum prostate specific antigen levels after transurethral resection of prostate: a longitudinal characterization in men with benign prostatic hyperplasia, J Urol, 156, 1035, 10.1016/S0022-5347(01)65694-5